These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


212 related items for PubMed ID: 6418112

  • 1. Experiments on the influence of combined application of N-methylnitrosourea and 7,12-dimethylbenzanthracene in female Sprague-Dawley rats.
    Berger M, Künstler K.
    Arch Geschwulstforsch; 1983; 53(5):423-7. PubMed ID: 6418112
    [Abstract] [Full Text] [Related]

  • 2. Effects of isoproterenol on mammary gland tumors induced by N-nitroso-N-methylurea and salivary gland tumors induced by 7,12-dimethylbenz[a]anthracene.
    Barka T.
    J Natl Cancer Inst; 1982 Nov; 69(5):1115-20. PubMed ID: 6813551
    [Abstract] [Full Text] [Related]

  • 3. [Influence of miskleron (clofibrate) on the carcinogenic effect of 7,12-dimethylbenz(alpha)anthracene and nitrosomethylurea in female rats].
    Anisimov VN, Danetskaia EV, Miretskiĭ GI, Troitskaia MN, Dil'man VM.
    Vopr Onkol; 1981 Nov; 27(3):64-7. PubMed ID: 6784339
    [No Abstract] [Full Text] [Related]

  • 4. [Studies on biological characterization of mammary tumours of the sprague-dawley-rat in the syngeneic tumour-host system. I. Spontaneous primary mammary tumours and tumours induced by oral and intravenous application of DMBA (author's transl)].
    Nowak C, Arnold W, Mehnert WH.
    Arch Geschwulstforsch; 1976 Nov; 46(7):549-54. PubMed ID: 827274
    [Abstract] [Full Text] [Related]

  • 5. Determination of the number of events required for mammary carcinogenesis in the Sprague-Dawley female rat.
    Isaacs JT.
    Cancer Res; 1985 Oct; 45(10):4827-32. PubMed ID: 3928142
    [Abstract] [Full Text] [Related]

  • 6. Lifetime dose-response relationships for mammary tumor induction by a single administration of N-methyl-N-nitrosourea.
    McCormick DL, Adamowski CB, Fiks A, Moon RC.
    Cancer Res; 1981 May; 41(5):1690-4. PubMed ID: 7214338
    [Abstract] [Full Text] [Related]

  • 7. [Induction of mammary gland cancer in rats].
    Kisliakova ND, Verevkina GA, Ogorodnikova LS, Kucherova TI.
    Vopr Onkol; 1978 May; 24(8):93-7. PubMed ID: 99871
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Repeated administration of carcinogen in critical developmental periods increases susceptibility of female Wistar: han rats to mammary carcinogenesis induction.
    Bojková B, Ahlers I, Kubatka P, Mociková K, Mníchová M, Ahlersová E.
    Neoplasma; 2000 May; 47(4):230-3. PubMed ID: 11043827
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Synergistic effect of chronic prolactin suppression and retinoid treatment in the prophylaxis of N-methyl-N-nitrosourea-induced mammary tumorigenesis in female Sprague-Dawley rats.
    Welsch CW, Brown CK, Goodrich-Smith M, Chiusano J, Moon RC.
    Cancer Res; 1980 Sep; 40(9):3095-8. PubMed ID: 6893571
    [Abstract] [Full Text] [Related]

  • 12. N-methyl-N-nitrosourea-induced rat mammary tumors. Hormone responsiveness but lack of spontaneous metastasis.
    Williams JC, Gusterson B, Humphreys J, Monaghan P, Coombes RC, Rudland P, Neville AM.
    J Natl Cancer Inst; 1981 Jan; 66(1):147-55. PubMed ID: 6779042
    [Abstract] [Full Text] [Related]

  • 13. Influence of prolactin and growth hormone on rat mammary tumors induced by N-nitrosomethylurea.
    Rose DP, Noonan JJ.
    Cancer Res; 1982 Jan; 42(1):35-8. PubMed ID: 6797725
    [Abstract] [Full Text] [Related]

  • 14. Synergistic effect of MNU and DMBA in mammary carcinogenesis and H-ras activation in female Sprague-Dawley rats.
    Shirai K, Uemura Y, Fukumoto M, Tsukamoto T, Pascual R, Nandi S, Tsubura A.
    Cancer Lett; 1997 Nov 25; 120(1):87-93. PubMed ID: 9570390
    [Abstract] [Full Text] [Related]

  • 15. Induction of mammary gland carcinomas by the subcutaneous injection of 1-methyl-1-nitrosourea.
    Thompson HJ, Meeker LD.
    Cancer Res; 1983 Apr 25; 43(4):1628-9. PubMed ID: 6831409
    [Abstract] [Full Text] [Related]

  • 16. Enhanced inhibition of mammary carcinogenesis by combined treatment with N-(4-hydroxyphenyl)retinamide and ovariectomy.
    McCormick DL, Mehta RG, Thompson CA, Dinger N, Caldwell JA, Moon RC.
    Cancer Res; 1982 Feb 25; 42(2):508-12. PubMed ID: 6459843
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Blastomogenesis in repeated administration of DMBA in rats during different life periods].
    P'rvanova LG.
    Vopr Onkol; 1978 Feb 25; 24(11):96-9. PubMed ID: 105473
    [Abstract] [Full Text] [Related]

  • 19. Sulfone metabolite of sulindac inhibits mammary carcinogenesis.
    Thompson HJ, Jiang C, Lu J, Mehta RG, Piazza GA, Paranka NS, Pamukcu R, Ahnen DJ.
    Cancer Res; 1997 Jan 15; 57(2):267-71. PubMed ID: 9000566
    [Abstract] [Full Text] [Related]

  • 20. Induction of mammary tumors in virgin female BALB/c mice by single low doses of 7,12-dimethylbenz[a]anthracene.
    Ethier SP, Ullrich RL.
    J Natl Cancer Inst; 1982 Nov 15; 69(5):1199-203. PubMed ID: 6813553
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.